Apogee Therapeutics Soars, Synopsys Gains, Norwegian Cruise Rises on Decline in Cost of Oil
On this episode of Stock Movers: - Apogee Therapeutics (APGE) soars after the drug developer provided maintenance data from a mid-stage trial that showed its experimental therapy deepened responses in patients with moderate-to-severe atopic dermatitis. - Synopsys (SNPS) shares gain following reports that activist investor Elliott Investment Management has made a multibillion-dollar investment in the chip-design software company. - Norwegian Cruise (NCLH) shares rose. Cruise companies traded higher in response to a decline in the cost of oil.See omnystudio.com/listener for privacy information.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.